Tiotropium bromide

Details

Files

Generic Name:

Tiotropium bromide

Project Status:

Complete

Therapeutic Area:

Chronic obstructive pulmonary disease

Manufacturer:

Boehringer Ingelheim (Canada) Ltd.

Call for patient/clinician input open:

November 27, 2014

Brand Name:

Spiriva Respimat

Project Line:

Reimbursement Review

Project Number:

SR0412-000

Call for patient/clinician input closed:

January 23, 2015

NOC Status at Filing:

Post NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Chronic Obstructive Pulmonary Disease (COPD)

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

July 16, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : May 23, 2018